Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free SPAI Stock Alerts

Safe Pro Group (SPAI) Competitors

Safe Pro Group logo
$3.64 -0.04 (-1.09%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$3.60 -0.04 (-1.24%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SPAI vs. TMCI, SGHT, CNXU, PROF, and TLSI

Should you buy Safe Pro Group stock or one of its competitors? MarketBeat compares Safe Pro Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Safe Pro Group include Treace Medical Concepts (TMCI), Sight Sciences (SGHT), Conexeu Sciences (CNXU), Profound Medical (PROF), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

How does Safe Pro Group compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Treace Medical Concepts had 4 more articles in the media than Safe Pro Group. MarketBeat recorded 5 mentions for Treace Medical Concepts and 1 mentions for Safe Pro Group. Safe Pro Group's average media sentiment score of 0.95 beat Treace Medical Concepts' score of 0.27 indicating that Safe Pro Group is being referred to more favorably in the news media.

Company Overall Sentiment
Treace Medical Concepts Neutral
Safe Pro Group Positive

Treace Medical Concepts has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3.52, suggesting that its share price is 252% more volatile than the broader market.

Safe Pro Group has lower revenue, but higher earnings than Treace Medical Concepts. Safe Pro Group is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$207.32M1.25-$59M-$0.97N/A
Safe Pro Group$610K124.66-$14.32M-$0.71N/A

Treace Medical Concepts currently has a consensus price target of $4.97, indicating a potential upside of 24.25%. Safe Pro Group has a consensus price target of $11.00, indicating a potential upside of 202.20%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts clearly believe Safe Pro Group is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
2 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.86
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Treace Medical Concepts has a net margin of -29.44% compared to Safe Pro Group's net margin of -800.91%. Treace Medical Concepts' return on equity of -67.04% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-29.44% -67.04% -30.28%
Safe Pro Group -800.91%-119.17%-107.17%

84.1% of Treace Medical Concepts shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 54.8% of Safe Pro Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Safe Pro Group beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks.

How does Safe Pro Group compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

Sight Sciences has a net margin of -46.83% compared to Safe Pro Group's net margin of -800.91%. Sight Sciences' return on equity of -52.34% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-46.83% -52.34% -28.49%
Safe Pro Group -800.91%-119.17%-107.17%

Sight Sciences has a beta of 2.38, suggesting that its share price is 138% more volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3.52, suggesting that its share price is 252% more volatile than the broader market.

Sight Sciences currently has a consensus price target of $8.25, indicating a potential upside of 68.02%. Safe Pro Group has a consensus price target of $11.00, indicating a potential upside of 202.20%. Given Safe Pro Group's stronger consensus rating and higher possible upside, analysts plainly believe Safe Pro Group is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Sight Sciences had 2 more articles in the media than Safe Pro Group. MarketBeat recorded 3 mentions for Sight Sciences and 1 mentions for Safe Pro Group. Safe Pro Group's average media sentiment score of 0.95 beat Sight Sciences' score of 0.62 indicating that Safe Pro Group is being referred to more favorably in the news media.

Company Overall Sentiment
Sight Sciences Positive
Safe Pro Group Positive

55.5% of Sight Sciences shares are owned by institutional investors. 30.4% of Sight Sciences shares are owned by company insiders. Comparatively, 54.8% of Safe Pro Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Safe Pro Group has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$79.55M3.36-$38.43M-$0.71N/A
Safe Pro Group$610K124.66-$14.32M-$0.71N/A

Summary

Safe Pro Group beats Sight Sciences on 9 of the 16 factors compared between the two stocks.

How does Safe Pro Group compare to Conexeu Sciences?

Safe Pro Group (NASDAQ:SPAI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Safe Pro Group presently has a consensus target price of $11.00, suggesting a potential upside of 202.20%. Conexeu Sciences has a consensus target price of $20.00, suggesting a potential upside of 133.37%. Given Safe Pro Group's higher probable upside, research analysts clearly believe Safe Pro Group is more favorable than Conexeu Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Conexeu Sciences
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Conexeu Sciences has a net margin of 0.00% compared to Safe Pro Group's net margin of -800.91%. Conexeu Sciences' return on equity of 0.00% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
Conexeu Sciences N/A N/A N/A

Conexeu Sciences has lower revenue, but higher earnings than Safe Pro Group. Conexeu Sciences is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K124.66-$14.32M-$0.71N/A
Conexeu SciencesN/AN/AN/A-$0.11N/A

In the previous week, Conexeu Sciences had 10 more articles in the media than Safe Pro Group. MarketBeat recorded 11 mentions for Conexeu Sciences and 1 mentions for Safe Pro Group. Safe Pro Group's average media sentiment score of 0.95 beat Conexeu Sciences' score of 0.19 indicating that Safe Pro Group is being referred to more favorably in the media.

Company Overall Sentiment
Safe Pro Group Positive
Conexeu Sciences Neutral

Summary

Safe Pro Group and Conexeu Sciences tied by winning 5 of the 10 factors compared between the two stocks.

How does Safe Pro Group compare to Profound Medical?

Safe Pro Group (NASDAQ:SPAI) and Profound Medical (NASDAQ:PROF) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Profound Medical has a net margin of -206.76% compared to Safe Pro Group's net margin of -800.91%. Profound Medical's return on equity of -78.88% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
Profound Medical -206.76%-78.88%-64.06%

47.9% of Profound Medical shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Safe Pro Group has higher earnings, but lower revenue than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K124.66-$14.32M-$0.71N/A
Profound Medical$18.81M14.02-$42.57M-$1.24N/A

In the previous week, Profound Medical had 2 more articles in the media than Safe Pro Group. MarketBeat recorded 3 mentions for Profound Medical and 1 mentions for Safe Pro Group. Profound Medical's average media sentiment score of 1.33 beat Safe Pro Group's score of 0.95 indicating that Profound Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Safe Pro Group Positive
Profound Medical Positive

Safe Pro Group presently has a consensus target price of $11.00, indicating a potential upside of 202.20%. Profound Medical has a consensus target price of $12.00, indicating a potential upside of 65.29%. Given Safe Pro Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Safe Pro Group is more favorable than Profound Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Profound Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Safe Pro Group has a beta of 3.52, meaning that its share price is 252% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Summary

Safe Pro Group beats Profound Medical on 9 of the 16 factors compared between the two stocks.

How does Safe Pro Group compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

In the previous week, TriSalus Life Sciences and TriSalus Life Sciences both had 1 articles in the media. TriSalus Life Sciences' average media sentiment score of 1.89 beat Safe Pro Group's score of 0.95 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Very Positive
Safe Pro Group Positive

TriSalus Life Sciences has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3.52, indicating that its share price is 252% more volatile than the broader market.

2.6% of TriSalus Life Sciences shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 54.8% of Safe Pro Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TriSalus Life Sciences currently has a consensus target price of $7.50, indicating a potential upside of 77.73%. Safe Pro Group has a consensus target price of $11.00, indicating a potential upside of 202.20%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts clearly believe Safe Pro Group is more favorable than TriSalus Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

TriSalus Life Sciences has a net margin of -60.85% compared to Safe Pro Group's net margin of -800.91%. TriSalus Life Sciences' return on equity of 0.00% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-60.85% N/A -69.91%
Safe Pro Group -800.91%-119.17%-107.17%

Safe Pro Group has lower revenue, but higher earnings than TriSalus Life Sciences. Safe Pro Group is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88M5.77-$39.23M-$1.41N/A
Safe Pro Group$610K124.66-$14.32M-$0.71N/A

Summary

TriSalus Life Sciences and Safe Pro Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Safe Pro Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPAI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPAI vs. The Competition

Export
MetricSafe Pro GroupTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$76.86M$3.81B$6.84B$12.25B
Dividend YieldN/A2.21%3.09%9.79%
P/E Ratio-5.1333.8528.1523.64
Price / Sales124.6639.67312.2389.03
Price / CashN/A34.0922.6859.64
Price / Book4.333.845.466.07
Net Income-$14.32M$31.76M$205.01M$331.99M
7 Day Performance-6.43%-1.90%-1.95%-0.63%
1 Month Performance-7.85%-7.80%-2.71%-2.00%
1 Year Performance-4.21%-6.23%4.47%13.62%

Safe Pro Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPAI
Safe Pro Group
3.198 of 5 stars		$3.64
-1.1%		$11.00
+202.2%		-3.2%$76.02M$610KN/A11
TMCI
Treace Medical Concepts
3.1412 of 5 stars		$4.44
-3.1%		$4.77
+7.4%		-30.9%$297.12M$212.69MN/A250
SGHT
Sight Sciences
2.6805 of 5 stars		$5.05
-5.4%		$8.25
+63.4%		+37.9%$290.55M$77.36MN/A210
CNXU
Conexeu Sciences
3.0146 of 5 stars		$9.50
-8.1%		$20.00
+110.5%		N/A$276.68MN/AN/A4
PROF
Profound Medical
2.1936 of 5 stars		$7.10
-0.7%		$12.00
+69.0%		+23.1%$259.84M$16.10MN/A150

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SPAI) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel